Search Results - "Miedico, A."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma: experience in 17 cases by Brambilla, L., Romanelli, A., Bellinvia, M., Ferrucci, S., Vinci, M., Boneschi, V., Miedico, A., Tedeschi, L.

    Published in British journal of dermatology (1951) (01-06-2008)
    “…Summary Background  Paclitaxel has proved to be highly effective in the treatment of severe AIDS‐related Kaposi sarcoma (KS), for which it is now considered as…”
    Get full text
    Journal Article
  2. 2

    Management and long-term follow-up of early stage H. pylori -associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study by Andriani, A, Miedico, A, Tedeschi, L, Patti, C, Di Raimondo, F, Leone, M, Schinocca, L, Romanelli, A, Bonanno, G, Linea, C, Giustini, M, Hassan, C, Cottone, M, Zullo, A

    Published in Digestive and liver disease (01-07-2009)
    “…Abstract Background/Aim Data on management and long-term follow-up of Helicobacter pylori -associated MALT-lymphoma in clinical practice are scanty. We…”
    Get full text
    Journal Article
  3. 3

    Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma by Brambilla, L, Miedico, A, Ferrucci, S, Romanelli, A, Brambati, M, Vinci, M, Tedeschi, L, Boneschi, V

    “…Background  Classic KS (CKS) mainly affects elderly people, has an irregular course, and is relatively benign for years. However, sometimes the disease may…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Consumption of C4b‐binding protein (C4BP) during in vivo activation of the classical complement pathway by BERGAMASCHINI, L., MIEDICO, A., CICARDI, M., COPPOLA, R., FAIONI, E. N., AGOSTONI, A.

    Published in Clinical and experimental immunology (01-05-1999)
    “…C4BP has a central role in regulating the classical complement (C′) pathway, but it is still uncertain whether or not it is consumed during in vivo complement…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8